Table 5. Overall diagnostic performance of EBUS-TBNA for various pathologies in patients with isolated mediastinal and/or hilar lymphadenopathy.

	Overall (%)	Lymphoma (%)	Sarcoidosis (%)	Carcinoma (%)
Sensitivity (95% CI)	81.6 (74.2–87.6)	26.7 (7.8–55.1)	86.7 (79.1–92.4)	100 (59.0–100)
NPV (95% CI)	74.8 (65.2–82.8)	95.9 (91.0–97.4)	87.5 (80.2–92.8)	100 (98.3–100)
Diagnostic accuracy	87.7	94.9	92.7	100
Disease prevalence	64.7	6.9	51.6	3.2

EBUS-TBNA, endobronchial ultrasound transbronchial aspiration.